JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SAMPSON, W. L.
Right arrow Articles by FERNANDEZ, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SAMPSON, W. L.
Right arrow Articles by FERNANDEZ, L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 65, Issue 3, 275-280, 1939
Copyright © 1939 by American Society for Pharmacology and Experimental Therapeutics


EXPERIMENTAL CONVULSIONS IN THE RAT

W. L. SAMPSON 1 and L. FERNANDEZ 1

1 From Merck Institute of Therapeutic Research, Rahway, New Jersey

1. The rat is as satisfactory for the production of experimental convulsions as the rabbit or cat hitherto used for this purpose.

2. Of the three convulsants; picrotoxin, camphor and thujone, the last is the most satisfactory for the study of experimental convulsions, since its convulsant dose is well below its minimum lethal dose and its effects quite rapidly wear off.

3. While the individual response to thujone varies considerably, the percentage of a group of rats responding with convulsions to a fixed dose of thujone is remarkably constant.

4. The convulsive dose of camphor is close to the lethal dose and its duration of action is so prolonged that repeated injections are inadvisable.

5. The dose of picrotoxin necessary to produce pronounced spontaneous convulsions is greater than the minimum lethal dose of this drug.

6. Sodium phenobarbital, sodium bromide or chloretone will decrease or abolish the incidence of thujone convulsions in the rat. This effect persists for from one to several days after the last administration of the drug. Bulbocapnin is without effect on thujone convulsions.

Submitted on July 16, 1938







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1939 by the American Society for Pharmacology and Experimental Therapeutics.